ML Lab, Shire Pharmaceuticals Group plc sales and marketing update

SHP will return European marketing rights to Adept icodextrin to MLB effective Dec. 30. The drug is approved to reduce post-operative abdominal adhesions in the EU, where it has annual sales of $5 mil...